InvestorsHub Logo
Followers 185
Posts 12470
Boards Moderated 0
Alias Born 10/09/2012

Re: Ice86 post# 64317

Tuesday, 04/29/2014 2:34:56 PM

Tuesday, April 29, 2014 2:34:56 PM

Post# of 91007
http://www.amjmed.com/article/S0002-9343(14)00079-5/fulltext


Conclusions
We postulate that the intramyocardial administration of multi-potent adipose-derived stromal vascular fraction cells and their diverse composition guided engraftment in the damaged area, facilitated the cardiomyocyte regenerative properties, and helped improve cardiac function. Because subcutaneous adipose tissue is readily available in most patients, adipose-derived stromal vascular fraction cells present a feasible clinical intervention for cardiac dysfunction. The population complexity, which includes stromal vascular fraction and growth factors, likely promotes repair by recruiting cardiomyocytes. The autologous nature and multi-potency of these cells may contribute to them being ideal for cardiac function restoration.


Acknowledgments
The authors thank Dr Steven Victor and Stephanie Squicciarini of IntelliCell Biosciences Inc (New York, NY) for supplying stromal vascular fraction, Dr Craig Hurst for providing lipoaspirate, and the patient
and family.

GO SVFC $$$$






















Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.